Davos 2025: ETFs To Tackle Geopolitical, Climate, Cyber Risks
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 15 2025
0mins
Source: Benzinga
Global Risks Report 2025: The World Economic Forum's report highlights significant risks for the upcoming year, including geopolitical tensions, climate change, and disinformation, urging investors to adopt strategies that leverage ETFs in response to these challenges.
Investment Strategies with ETFs: The report suggests specific ETFs, such as defense, clean energy, and cybersecurity funds, as effective tools for investors to navigate the turbulent economic landscape and build resilient portfolios amid rising global uncertainties.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MKC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MKC
Wall Street analysts forecast MKC stock price to rise
3 Analyst Rating
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 52.910
Low
75.00
Averages
83.67
High
89.00
Current: 52.910
Low
75.00
Averages
83.67
High
89.00
About MKC
McCormick & Company, Incorporated manufactures, markets, and distributes herbs, spices, seasonings, condiments and flavors to the entire food and beverage industry, including retailers, food manufacturers and foodservice businesses. It operates through two segments: consumer and flavor solutions. The consumer segment sells to retail channels, including grocery, mass merchandise, warehouse clubs, discount and drug stores, and e-commerce under the McCormick brand and a variety of brands around the world, including French's, Frank's RedHot, Lawry’s, Zatarain’s, Simply Asia, Thai Kitchen, Ducros, Vahine, Cholula, Schwartz, Club House, Kamis, DaQiao, La Drogheria, Stubb's, OLD BAY, Gourmet Garden, and others. In its flavor solutions segment, it provides a range of products to multinational food manufacturers and foodservice customers. The foodservice customers are supplied with branded, packaged products both directly by the Company and indirectly through distributors.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
UK M&A Market Booms Amid Valuation Gap
- Surge in M&A Activity: According to Citi UK CEO Tiina Lee, the UK M&A market is booming, particularly as large companies simplify their business portfolios to focus on core operations, with 28 transactions announced in 2023 indicating strong foreign investment trends.
- Rising Deal Values: Despite a 12% decline in the number of deals last year, the total value of transactions increased by approximately 12%, suggesting that strategic buyers and private equity firms are increasingly targeting high-quality assets, with average deal sizes soaring by 30%.
- Focus on Core Competencies: Lee highlighted transactions such as McCormick's deal with Unilever's food business and Diageo's sale of its Indian cricket team as examples of major companies sharpening their focus around core competencies, reflecting a strategic shift in the market.
- Weak IPO Market: In contrast to the active M&A landscape, the UK IPO market remains relatively weak, although 2025 is projected to be the strongest year for London IPO activity since 2021, with overall volumes still below previous year levels.
See More
Unilever Explores Bid for Thorne Supplements
- Acquisition Interest: Unilever is exploring a bid for U.S. supplements maker Thorne, indicating its acceleration towards beauty and wellness brands under CEO Fernando Fernandez, aiming to enhance market competitiveness.
- Market Valuation: Valued at up to $4 billion, Thorne primarily sells dietary supplements like magnesium and omega-3, and Unilever's interest reflects its commitment to the health product market, potentially enriching its product portfolio.
- Strategic Realignment: Since taking over in March 2025, Fernandez has begun reshaping Unilever's portfolio, recently announcing the merger of its food business with U.S. spice maker McCormick, highlighting a strategic focus on health and beauty.
- Competitive Landscape: Thorne has attracted interest from multiple strategic investors, including Haleon, which focuses on faster-growing health categories, suggesting that Unilever's acquisition interest may intensify market competition and drive industry consolidation.
See More
US Stocks Close Mixed: Tech Stocks Weigh on Market
- Tech Stock Weakness: Apple’s stock fell over 6% after raising prices on Macs, iPads, and Vision Pro to offset memory chip shortages, significantly dragging down the S&P 500 and Dow Jones Industrial Average, highlighting the vulnerability of tech stocks in the current market.
- Chip Sector Strength: Micron Technology’s forecast of $50 billion in Q4 revenue, well above the $43.24 billion consensus, led to a 15% stock surge, bolstering investor confidence in the AI sector and potentially driving growth across related industries.
- Positive Economic Data: Initial jobless claims fell to 215,000, below the expected 225,000, indicating a robust labor market, while May personal spending and income exceeded expectations, suggesting sustained consumer spending that could support the stock market.
- International Market Rally: European and Asian stock markets closed higher, with the Euro Stoxx 50 and Japan’s Nikkei 225 rising by 0.85% and 4.61%, respectively, reflecting global optimism about the US economic recovery, which may provide support for US stocks.
See More
McCormick Reports 14% Sales Growth in Q2 Driven by Acquisition
- Sales Growth Highlight: McCormick achieved a 14% sales growth in Q2, with 12% stemming from the acquisition of McCormick de Mexico and 2% from organic growth, demonstrating the company's success in market expansion and acquisition integration, thereby enhancing its competitive position in the seasoning industry.
- Gross Margin Expansion: The company expanded its gross profit margin by 270 basis points, driven by contributions from McCormick de Mexico, tariff refunds, and savings from its Comprehensive Continuous Improvement program, indicating effective strategies in cost control and efficiency improvements that further solidify its profitability.
- Cash Flow Performance: Operating cash flow reached $431 million in the first half, a significant increase from $161 million in the prior year, reflecting substantial improvements in cash management and operational efficiency, providing ample funding for future investments and expansion.
- Market Challenge Response: Despite facing challenges such as softening consumption trends and widening price gaps in the U.S. spices and seasonings category, the company actively responds through digital advancements and targeted solutions, showcasing its agility in navigating uncertain market conditions.
See More
US Stocks Rise Slightly, Led by Chipmakers
- Chipmaker Surge: US stocks rose today, led by Micron Technology's forecast of $50 billion in Q4 revenue, significantly above the $43.24 billion consensus, resulting in an 11% stock price increase and bolstering the bullish case for AI trades.
- Positive Economic Indicators: US economic data revealed an upward revision of Q1 GDP to 2.1%, surpassing the expected 1.6%, while weekly initial jobless claims fell by 12,000 to 215,000, indicating a robust labor market that enhances market confidence.
- Improved Inflation Expectations: The May core PCE price index rose 3.4% year-over-year, aligning with expectations, and the 10-year Treasury yield dropped to a 6-week low of 4.36%, providing support for stocks and alleviating investor concerns about rate hikes.
- Apple's Stock Decline: Despite overall market gains, Apple's stock fell over 5% after raising prices on Macs and iPads to offset memory chip shortages, which limited the broader market's upward momentum.
See More
Biotech Stocks Surge Amid Positive Trials and Earnings
- Biotech Breakthrough: Kymera Therapeutics enrolled in a Phase 2b Broaden2 trial for its KT-621 drug aimed at treating atopic dermatitis, leading to a 17% stock surge, indicating potential market share growth in the therapeutic area.
- BlackBerry Earnings Beat: BlackBerry reported fiscal Q1 adjusted earnings of 4 cents per share on revenue of $152.9 million, exceeding analyst expectations, resulting in a 20% stock increase, reflecting a recovery in its software business and enhanced market confidence.
- Apple Price Hike: Apple announced price increases for MacBooks and iPads, causing its shares to drop nearly 5%, driven by rising memory and storage costs, which may impact consumer purchasing decisions and future sales.
- Hertz Stock Decline: Hertz Global's stock fell over 9% following a 37 million share secondary offering priced at $2.70 per share, with proceeds going to JPMorgan, potentially affecting market liquidity and investor confidence despite Hertz not receiving direct benefits.
See More
UK M&A Market Booms Amid Valuation Gap
- Surge in M&A Activity: According to Citi UK CEO Tiina Lee, the UK M&A market is booming, particularly as large companies simplify their business portfolios to focus on core operations, with 28 transactions announced in 2023 indicating strong foreign investment trends.
- Rising Deal Values: Despite a 12% decline in the number of deals last year, the total value of transactions increased by approximately 12%, suggesting that strategic buyers and private equity firms are increasingly targeting high-quality assets, with average deal sizes soaring by 30%.
- Focus on Core Competencies: Lee highlighted transactions such as McCormick's deal with Unilever's food business and Diageo's sale of its Indian cricket team as examples of major companies sharpening their focus around core competencies, reflecting a strategic shift in the market.
- Weak IPO Market: In contrast to the active M&A landscape, the UK IPO market remains relatively weak, although 2025 is projected to be the strongest year for London IPO activity since 2021, with overall volumes still below previous year levels.
See More
Unilever Explores Bid for Thorne Supplements
- Acquisition Interest: Unilever is exploring a bid for U.S. supplements maker Thorne, indicating its acceleration towards beauty and wellness brands under CEO Fernando Fernandez, aiming to enhance market competitiveness.
- Market Valuation: Valued at up to $4 billion, Thorne primarily sells dietary supplements like magnesium and omega-3, and Unilever's interest reflects its commitment to the health product market, potentially enriching its product portfolio.
- Strategic Realignment: Since taking over in March 2025, Fernandez has begun reshaping Unilever's portfolio, recently announcing the merger of its food business with U.S. spice maker McCormick, highlighting a strategic focus on health and beauty.
- Competitive Landscape: Thorne has attracted interest from multiple strategic investors, including Haleon, which focuses on faster-growing health categories, suggesting that Unilever's acquisition interest may intensify market competition and drive industry consolidation.
See More
US Stocks Close Mixed: Tech Stocks Weigh on Market
- Tech Stock Weakness: Apple’s stock fell over 6% after raising prices on Macs, iPads, and Vision Pro to offset memory chip shortages, significantly dragging down the S&P 500 and Dow Jones Industrial Average, highlighting the vulnerability of tech stocks in the current market.
- Chip Sector Strength: Micron Technology’s forecast of $50 billion in Q4 revenue, well above the $43.24 billion consensus, led to a 15% stock surge, bolstering investor confidence in the AI sector and potentially driving growth across related industries.
- Positive Economic Data: Initial jobless claims fell to 215,000, below the expected 225,000, indicating a robust labor market, while May personal spending and income exceeded expectations, suggesting sustained consumer spending that could support the stock market.
- International Market Rally: European and Asian stock markets closed higher, with the Euro Stoxx 50 and Japan’s Nikkei 225 rising by 0.85% and 4.61%, respectively, reflecting global optimism about the US economic recovery, which may provide support for US stocks.
See More
McCormick Reports 14% Sales Growth in Q2 Driven by Acquisition
- Sales Growth Highlight: McCormick achieved a 14% sales growth in Q2, with 12% stemming from the acquisition of McCormick de Mexico and 2% from organic growth, demonstrating the company's success in market expansion and acquisition integration, thereby enhancing its competitive position in the seasoning industry.
- Gross Margin Expansion: The company expanded its gross profit margin by 270 basis points, driven by contributions from McCormick de Mexico, tariff refunds, and savings from its Comprehensive Continuous Improvement program, indicating effective strategies in cost control and efficiency improvements that further solidify its profitability.
- Cash Flow Performance: Operating cash flow reached $431 million in the first half, a significant increase from $161 million in the prior year, reflecting substantial improvements in cash management and operational efficiency, providing ample funding for future investments and expansion.
- Market Challenge Response: Despite facing challenges such as softening consumption trends and widening price gaps in the U.S. spices and seasonings category, the company actively responds through digital advancements and targeted solutions, showcasing its agility in navigating uncertain market conditions.
See More
US Stocks Rise Slightly, Led by Chipmakers
- Chipmaker Surge: US stocks rose today, led by Micron Technology's forecast of $50 billion in Q4 revenue, significantly above the $43.24 billion consensus, resulting in an 11% stock price increase and bolstering the bullish case for AI trades.
- Positive Economic Indicators: US economic data revealed an upward revision of Q1 GDP to 2.1%, surpassing the expected 1.6%, while weekly initial jobless claims fell by 12,000 to 215,000, indicating a robust labor market that enhances market confidence.
- Improved Inflation Expectations: The May core PCE price index rose 3.4% year-over-year, aligning with expectations, and the 10-year Treasury yield dropped to a 6-week low of 4.36%, providing support for stocks and alleviating investor concerns about rate hikes.
- Apple's Stock Decline: Despite overall market gains, Apple's stock fell over 5% after raising prices on Macs and iPads to offset memory chip shortages, which limited the broader market's upward momentum.
See More
Biotech Stocks Surge Amid Positive Trials and Earnings
- Biotech Breakthrough: Kymera Therapeutics enrolled in a Phase 2b Broaden2 trial for its KT-621 drug aimed at treating atopic dermatitis, leading to a 17% stock surge, indicating potential market share growth in the therapeutic area.
- BlackBerry Earnings Beat: BlackBerry reported fiscal Q1 adjusted earnings of 4 cents per share on revenue of $152.9 million, exceeding analyst expectations, resulting in a 20% stock increase, reflecting a recovery in its software business and enhanced market confidence.
- Apple Price Hike: Apple announced price increases for MacBooks and iPads, causing its shares to drop nearly 5%, driven by rising memory and storage costs, which may impact consumer purchasing decisions and future sales.
- Hertz Stock Decline: Hertz Global's stock fell over 9% following a 37 million share secondary offering priced at $2.70 per share, with proceeds going to JPMorgan, potentially affecting market liquidity and investor confidence despite Hertz not receiving direct benefits.
See More
